Pregnancy after valproate withdrawal—Fetal malformations and seizure control
暂无分享,去创建一个
M. Eadie | A. Hitchcock | J. Graham | F. Vajda | C. Lander | T. O’Brien
[1] M. Manfredi,et al. Doing without valproate in women of childbearing potential with idiopathic generalized epilepsy: Implications on seizure outcome , 2019, Epilepsia.
[2] T. Tomson,et al. Declining malformation rates with changed antiepileptic drug prescribing , 2019, Neurology.
[3] G. Koren,et al. Dose-Dependent Risk of Malformations With Antiepileptic Drugs: An Analysis of Data From the EURAP Epilepsy and Pregnancy Registry , 2015, Therapeutic drug monitoring.
[4] T. O'Brien,et al. Valproate still has a place in women with epilepsy , 2015, Epilepsia.
[5] K. Meador,et al. IQ at 6 years after in utero exposure to antiepileptic drugs , 2015, Neurology.
[6] T. O'Brien,et al. Dose dependence of fetal malformations associated with valproate , 2013, Neurology.
[7] T. Tomson,et al. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry , 2011, The Lancet Neurology.
[8] T. O'Brien,et al. Changing patterns of antiepileptic drug use in pregnant Australian women , 2010, Acta neurologica Scandinavica.
[9] M. Eadie,et al. Seizure control in antiepileptic drug‐treated pregnancy , 2008, Epilepsia.
[10] M. Eadie,et al. The Australian antiepileptic drug in pregnancy register: Aspects of data collection and analysis , 2007, Journal of Clinical Neuroscience.
[11] T. O'Brien,et al. Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy , 2004, Journal of clinical neuroscience.
[12] M. Riley,et al. Birth Defects in Victoria 1983–1998 , 2000 .
[13] K. Inanaga,et al. Multi‐institutional Study on the Teratogenicity and Fetal Toxicity of Antiepileptic Drugs: A Report of a Collaborative Study Group in Japan , 1980, Epilepsia.